VCEL vs VIR: stock comparison and AI forecast
Vericel Corp (VCEL) and Vir Biotechnology, Inc. (VIR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
VCEL Vericel Corp
- Price
- $42.91 +23.6% · 6M
- Market Cap
- $2.20B
- P/E Ratio
- 116.0x
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
VIR Vir Biotechnology, Inc.
- Price
- $11.75 +15.0% · 6M
- Market Cap
- $1.99B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- VCEL is 1.1 times larger than VIR by market capitalization ($2.20B against $1.99B).
- Over the last six months VCEL returned +23.6% and VIR +15.0%.
- VCEL turns 7.9% of its revenue into net income, against -68.5% for VIR.
- VCEL carries 0.36 times debt per unit of equity, against 0.24 times for VIR.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | VCEL | VIR |
|---|---|---|
| Market Cap | $2.20B | $1.99B |
| P/E Ratio | 115.97x | – |
| P/B Ratio | 5.94x | 2.02x |
| EPS | $0.37 | $-1.89 |
| Book Value/Share | $7.23 | $5.81 |
| Revenue/Share | $5.98 | – |
| FCF/Share | $1.20 | $-1.20 |
Profitability & Margins
| Metric | VCEL | VIR |
|---|---|---|
| ROE | 6.5% | -25.6% |
| ROA | 4.8% | -20.7% |
| ROIC | 4.0% | -25.0% |
| Gross Margin | 74.6% | 83.7% |
| Operating Margin | 6.0% | -76.3% |
| Net Margin | 7.9% | -68.5% |
| EBT Margin | 8.0% | -68.4% |
| Tax Rate | – | -0.1% |
Financial Health
| Metric | VCEL | VIR |
|---|---|---|
| Current Ratio | 5.04x | 6.04x |
| Quick Ratio | 4.69x | – |
| D/E Ratio | 0.36x | 0.24x |
| Financial Leverage | 1.36x | 1.24x |
| Interest Coverage | 45.8x | – |
| Working Capital | $212M | $479M |
Cash Flow
| Metric | VCEL | VIR |
|---|---|---|
| Operating Cash Flow | $70M | -$203M |
| Free Cash Flow | $62M | -$204M |
| Capital Spending | -$8M | -$1M |
| OCF Growth YoY | 47.5% | – |
| FCF/Sales | 20.1% | – |
| CapEx/Sales | 2.6% | – |
Operational Efficiency
| Metric | VCEL | VIR |
|---|---|---|
| Asset Turnover | 0.61x | – |
| Receivables Turnover | 4.0x | – |
| Inventory Turnover | 4.2x | – |
| Fixed Assets Turnover | 2.9x | – |
| Days Sales Outstanding | 90 days | – |
| Days Inventory | 86 days | – |
| Payables Period | 97 days | 249239 days |
| Cash Conversion Cycle | 80 days | – |
Income Statement
| Metric | VCEL | VIR |
|---|---|---|
| Total Revenue | $306M | – |
| Operating Income | $18M | -$280M |
| Net Income | $24M | -$252M |
| R&D Expense | $29M | $484M |
| SG&A Expense | $181M | $99M |
| Cost of Goods Sold | $78M | $30K |
Dividend & Shareholder Information
| Metric | VCEL | VIR |
|---|---|---|
| Shares Outstanding | 51M | 169M |
| Net Income Growth | 240.8% | – |
| EPS Growth | 27.6% | – |
VCEL vs VIR: stock comparison and AI forecast
Which is bigger, VCEL or VIR?
VCEL is 1.1 times larger than VIR by market capitalization ($2.20B against $1.99B).
Which stock performed better over the last six months, VCEL or VIR?
Over the last six months VCEL returned +23.6% and VIR +15.0%.
Which one does Intratio's AI model rank higher, VCEL or VIR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.